Transient up-regulation of P-glycoprotein reduces tacrolimus absorption after ischemia-reperfusion injury in rat ileum

Biochemical Pharmacology

Volumn 69, Issue 4, 2005, Pages 561-568

  Omae, Takanori ^a   Goto, Maki ^a   Shimomura, Masahiro ^a   Masuda, Satohiro ^a   Ito, Kimitaka ^a   Okuda, Masahiro ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

C219 monoclonal antibody; FK506; MDR1; Proliferation; Small bowel transplantation; Transporter

Indexed keywords

GLYCOPROTEIN P; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPT CELL; DRUG ABSORPTION; ILEUM; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE TRANSPLANTATION; INTESTINE VILLUS; INTESTINE WALL; ISCHEMIA; MALE; MORPHOLOGY; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BASEMENT MEMBRANE; BIOLOGICAL TRANSPORT; ILEUM; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; MALE; P-GLYCOPROTEIN; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA, MESSENGER; TACROLIMUS; UP-REGULATION;

EID: 12744277434     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.10.016     Document Type: Article

References (22)

1. S. Massberg, and K. Messmer The nature of ischemia-reperfusion injury Transplant Proc 30 1998 4217 4223
2. J.I. Gordon Intestinal epithelial differentiation: new insights from chimeric and transgenic mice J Cell Biol 108 1989 1187 1194
3. S. Zhi-Yong, Y.L. Dong, and X.H. Wang Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion J Trauma 32 1992 148 153
4. K.Y. Yeh, M. Yeh, and J. Glass Expression of intestinal brush-border membrane hydrolases and ferritin after segmental ischemia-reperfusion in rats Am J Physiol 275 1998 G572 G583
5. R.P. Rijke, W.R. Hanson, H.M. Plaisier, and J.W. Osborne The effect of ischemic villous cell damage on crypt cell proliferation in the small intestine: evidence for a feedback control mechanism Gastroenterology 71 1976 786 792
6. R. Udassin, A. Vromen, and Y. Haskel The time sequence of injury and recovery following transient reversible intestinal ischemia J Surg Res 56 1994 221 225
7. D.G. Farmer, S.V. McDiarmid, H. Yersiz, G. Cortina, F. Amersi, and J. Vargas Outcome after intestinal transplantation: results from one center's 9-year experience Arch Surg 136 2001 1027 1031 [Discussion 1031-2]
8. R. Venkataramanan, A. Swaminathan, T. Prasad, A. Jain, S. Zuckerman, and V. Warty Clinical pharmacokinetics of tacrolimus Clin Pharmacokinet 29 1995 404 430
9. M.F. Hebert Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery Adv Drug Deliv Rev 27 1997 201 214
10. J.M. Brady, N.J. Cherrington, D.P. Hartley, S.C. Buist, N. Li, and C.D. Klaassen Tissue distribution and chemical induction of multiple drug resistance genes in rats Drug Metab Dispos 30 2002 838 844
11. M. Shimomura, S. Masuda, H. Saito, S. Sakamoto, S. Uemoto, and K. Tanaka Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus J Surg Res 103 2002 215 222
12. S. Masuda, S. Uemoto, T. Hashida, Y. Inomata, K. Tanaka, and K. Inui Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient Clin Pharmacol Ther. 68 2000 98 103
13. H. Kiyozaki, E. Kobayashi, N. Toyama, and M. Miyata Segmental small bowel transplantation in the rat: comparison of lipid absorption between jejunal and ileum grafs J Parenter Enteral Nutr 20 1996 67
14. S. Masuda, S. Uemoto, M. Goto, Y. Fujimoto, K. Tanaka, and K. Inui Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients Clin Pharmacol Ther 75 2004 352 361
15. T. Hashida, S. Masuda, S. Uemoto, H. Saito, K. Tanaka, and K. Inui Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation Clin Pharmacol Ther 69 2001 308 316
16. T.A. Vos, J.E. Ros, R. Havinga, H. Moshage, F. Kuipers, and P.L. Jansen Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats Hepatology 29 1999 1833 1839
17. F. Beiche, S. Scheuerer, K. Brune, G. Geisslinger, and M. Goppelt-Struebe Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation FEBS Lett 390 1996 165 169
18. F. Zhang, J. Riley, and T.W. Gant Intrinsic multidrug class 1 and 2 gene expression and localization in rat and human mammary tumors Lab Invest 75 1996 413 426
19. N.J. Cherrington, A.L. Slitt, N. Li, and C.D. Klaassen Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats Drug Metab Dispos 32 2004 734 741
20. K.I. Hirsch-Ernst, C. Ziemann, C. Schmitz-Salue, H. Foth, and G.F. Kahl Modulation of P-glycoprotein and mdr1b mRNA expression by growth factors in primary rat hepatocyte culture Biochem Biophys Res Commun 215 1995 179 185
21. M. Goto, S. Masuda, H. Saito, and K. Inui Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2 Biochem Pharmacol 66 2003 163 170
22. A.E. Trezise, P.R. Romano, D.R. Gill, S.C. Hyde, F.V. Sepulveda, and M. Buchwald The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression EMBO J 11 1992 4291 4303